Background: Increasing evidence from rodent studies indicates that inhaled multi-walled carbon nanotubes (MWCNTs) have harmful effects on the lungs. In this study, we examined the effects of inhalation exposure to MWCNTs on allergen-induced airway inflammation and fibrosis. We hypothesized that inhalation pre-exposure to MWCNTs would render mice susceptible to developing allergic lung disease induced by house dust mite (HDM) allergen. Methods: Male B6C3F1/N mice were exposed by whole-body inhalation for 6 h a day, 5 d a week, for 30 d to air control or 0.06, 0.2, and 0.6 mg/m3 of MWCNTs. The exposure atmospheres were agglomerates (1.4-1.8 µm) composed of MWCNTs (average diameter 16 nm; average length 2.4 µm; 0.52% Ni). Mice then received 25 µg of HDM extract by intranasal instillation 6 times over 3 weeks. Necropsy was performed at 3 and 30 d after the final HDM dose to collect serum, bronchoalveolar lavage fluid (BALF), and lung tissue for histopathology. Results: MWCNT exposure at the highest dose inhibited HDM-induced serum IgE levels, IL-13 protein levels in BALF, and airway mucus production. However, perivascular and peribronchiolar inflammatory lesions were observed in the lungs of mice at 3 d with MWCNT and HDM, but not MWCNT or HDM alone. Moreover, combined HDM and MWCNT exposure increased airway fibrosis in the lungs of mice. Conclusions: Inhalation pre-exposure to MWCNTs inhibited HDM-induced TH2 immune responses, yet this combined exposure resulted in vascular inflammation and airway fibrosis, indicating that MWCNT pre-exposure alters the immune response to allergens.
Background: Increasing evidence from rodent studies indicates that inhaled multi-walled carbon nanotubes (MWCNTs) have harmful effects on the lungs. In this study, we examined the effects of inhalation exposure to MWCNTs on allergen-induced airway inflammation and fibrosis. We hypothesized that inhalation pre-exposure to MWCNTs would render mice susceptible to developing allergic lung disease induced by house dust mite (HDM) allergen. Methods: Male B6C3F1/N mice were exposed by whole-body inhalation for 6 h a day, 5 d a week, for 30 d to air control or 0.06, 0.2, and 0.6 mg/m3 of MWCNTs. The exposure atmospheres were agglomerates (1.4-1.8 µm) composed of MWCNTs (average diameter 16 nm; average length 2.4 µm; 0.52% Ni). Mice then received 25 µg of HDM extract by intranasal instillation 6 times over 3 weeks. Necropsy was performed at 3 and 30 d after the final HDM dose to collect serum, bronchoalveolar lavage fluid (BALF), and lung tissue for histopathology. Results:MWCNT exposure at the highest dose inhibited HDM-induced serum IgE levels, IL-13 protein levels in BALF, and airway mucus production. However, perivascular and peribronchiolar inflammatory lesions were observed in the lungs of mice at 3 d with MWCNT and HDM, but not MWCNT or HDM alone. Moreover, combined HDM and MWCNT exposure increased airway fibrosis in the lungs of mice. Conclusions: Inhalation pre-exposure to MWCNTs inhibited HDM-induced TH2 immune responses, yet this combined exposure resulted in vascular inflammation and airway fibrosis, indicating that MWCNT pre-exposure alters the immune response to allergens.
Authors: A A Shvedova; E R Kisin; D Porter; P Schulte; V E Kagan; B Fadeel; V Castranova Journal: Pharmacol Ther Date: 2008-12-06 Impact factor: 12.310
Authors: Matthew M Dahm; Mary K Schubauer-Berigan; Douglas E Evans; M Eileen Birch; Stephen Bertke; John D Beard; Aaron Erdely; Joseph E Fernback; Robert R Mercer; Sergey A Grinshpun Journal: Int J Hyg Environ Health Date: 2018-01-11 Impact factor: 5.840
Authors: Kelly A Shipkowski; Alexia J Taylor; Elizabeth A Thompson; Ellen E Glista-Baker; Brian C Sayers; Zachary J Messenger; Rebecca N Bauer; Ilona Jaspers; James C Bonner Journal: PLoS One Date: 2015-06-19 Impact factor: 3.240
Authors: Katherine S Duke; Alexia J Taylor-Just; Mark D Ihrie; Kelly A Shipkowski; Elizabeth A Thompson; Erinn C Dandley; Gregory N Parsons; James C Bonner Journal: Part Fibre Toxicol Date: 2017-07-17 Impact factor: 9.400
Authors: Jessica P Ryman-Rasmussen; Mark F Cesta; Arnold R Brody; Jeanette K Shipley-Phillips; Jeffrey I Everitt; Earl W Tewksbury; Owen R Moss; Brian A Wong; Darol E Dodd; Melvin E Andersen; James C Bonner Journal: Nat Nanotechnol Date: 2009-10-25 Impact factor: 39.213
Authors: Aaron Erdely; Matthew Dahm; Bean T Chen; Patti C Zeidler-Erdely; Joseph E Fernback; M Eileen Birch; Douglas E Evans; Michael L Kashon; James A Deddens; Tracy Hulderman; Suzan A Bilgesu; Lori Battelli; Diane Schwegler-Berry; Howard D Leonard; Walter McKinney; David G Frazer; James M Antonini; Dale W Porter; Vincent Castranova; Mary K Schubauer-Berigan Journal: Part Fibre Toxicol Date: 2013-10-21 Impact factor: 9.400
Authors: Mark D Ihrie; Katherine S Duke; Kelly A Shipkowski; Dorothy J You; Ho Young Lee; Alexia J Taylor-Just; James C Bonner Journal: NanoImpact Date: 2021-03-13
Authors: Christopher T Migliaccio; Raymond F Hamilton; Pamela K Shaw; Joseph F Rhoderick; Sanghamitra Deb; Rohit Bhargava; Jack R Harkema; Andrij Holian Journal: Part Fibre Toxicol Date: 2021-03-26 Impact factor: 9.400
Authors: Alexia J Taylor-Just; Mark D Ihrie; Katherine S Duke; Ho Young Lee; Dorothy J You; Salik Hussain; Vamsi K Kodali; Christina Ziemann; Otto Creutzenberg; Adriana Vulpoi; Flaviu Turcu; Monica Potara; Milica Todea; Sybille van den Brule; Dominique Lison; James C Bonner Journal: Part Fibre Toxicol Date: 2020-11-26 Impact factor: 9.400